Recently, literature has focused that SIRT1 can promote the proliferation, migration, and lipid metabolism in NPC cells, suggesting that SIRT1 is an attractive target to treat NPCs (14). The gene discussed is SIRT1; the disease is nasopharyngeal carcinoma.